Live news related to ARGENX SE stock (NL0010832176): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The biopharmaceutical group argenx announces the presentation of new clinical data for VYVGART and its drug candidates at the annual American Academy …
Argenx announces its annual general meeting on May 6, 2026, in the Netherlands. The meeting will include the review of the 2025 financial statements a…
Argenx announces through a press release that it will present new clinical data at the American Academy of Neurology (AAN) annual conference in April …
Argenx laboratory revealed on Thursday the positive results of its phase 3 ADAPT OCULUS clinical trial evaluating Vyvgart in the treatment of ocular m…
Argenx announces the participation of its Chief Operating Officer in a presentation at the 46th annual TD Cowen Health Conference. The event will take…
Goldman Sachs ajuste son objectif de cours sur argenX SE ce vendredi 13 février 2026.
DZ Bank AG Research ajuste sa position sur argenx SE ce mardi 13 janvier 2026.
Immunology company argenx announces that the U.S. Food and Drug Administration has agreed to prioritize the review of a supplemental indication for it…
Dutch biotechnology group argenx has announced preliminary net sales of $4.15 billion for fiscal year 2025, a 90% increase year-over-year. The company…
Immunology company argenx has announced a leadership transition, appointing current COO Karen Massey as the new CEO, according to a statement released…
